The Future of Colorectal Cancer Screening: Reaching the Unscreened episode artwork

EPISODE · Sep 10, 2026 · 22 MIN

The Future of Colorectal Cancer Screening: Reaching the Unscreened

from Becker’s Healthcare Podcast · host Becker's Healthcare

In this episode, Dr. AmirAli Talasaz, Co-Founder and Co-CEO of Guardant Health, discusses how blood-based screening can help close persistent colorectal cancer screening gaps and reach millions of unscreened patients. He also explores how the Shield Blood Test can increase screening participation, reconnect unscreened patients with health systems and enable earlier detection of colorectal cancer, particularly in rural and underserved communities.This episode is sponsored by Guardant Health.

Episode metadata supplied by the publisher feed · Published Sep 10, 2026

Embed this episode

Ready to play

The Future of Colorectal Cancer Screening: Reaching the Unscreened

0:00 22:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Becker’s Healthcare Podcast?

This episode is 22 minutes long.

When was this Becker’s Healthcare Podcast episode published?

This episode was published on September 10, 2026.

Can I download this Becker’s Healthcare Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!